Abstract: Disclosed is an exoskeleton-type rehabilitation robot system, including: a body part provided on a chair in which a user sits and provided with a robot arm capable of moving left or right based on the user seated on the chair; a conversion part configured to convert a position of the robot arm with respect to the body part; a driving part configured to articulate the robot arm with respect to the body part; and a controller configured to detect a change in a position of the robot arm and control a left or right driving mode of the driving part according to the position of the robot arm. In accordance with such a configuration, the exoskeleton-type rehabilitation robot system of the present invention is provided integrally with a chair, thereby having excellent space utilization. In addition, the user's initial preparation for rehabilitation training is simple, which can improve efficiency.

Abstract: A lithium secondary battery includes: a positive electrode; a negative electrode; a separator provided between the positive and negative electrodes; and an electrolyte. The positive electrode includes a positive electrode current collector and a positive electrode active material provided on the positive electrode current collector. The negative electrode includes a negative electrode current collector and a negative electrode active material layer provided on the negative electrode current collector. The positive electrode active material layer includes a positive electrode active material including a lithium composite transition metal compound which includes nickel, cobalt and manganese, where the nickel is in an amount from 80 mol % to 100 mol % among the metals except for lithium and is in the form of a single particle. The negative electrode active material layer includes a Si/C-based active material in an amount from 3 parts to 100 parts by weight of the entire negative electrode active material.

Abstract: The present invention provides a method for preventing or treating a liver disease selected from the group consisting of non-alcoholic fatty liver, non-alcoholic steatohepatitis and hepatic fibrosis comprising administrating at least one selected from the group consisting of an Ssu72 peptide, a polynucleotide encoding the Ssu72 peptide, and an expression vector comprising the polynucleotide.

Abstract: A complementary thin film transistor (TFT) includes a substrate and a first TFT and a second TFT disposed on the substrate, wherein a first conductive semiconductor layer of the first TFT and a second gate electrode layer of the second TFT are disposed in the same layer and include the same material.

Abstract: An ultrasonic image providing method of the present disclosure includes: receiving ultrasonic images; measuring a plurality of similarities for a plurality of measurement items for at least one of the ultrasonic images; comparing the plurality of similarities with corresponding default thresholds, respectively; when none of the plurality of similarities is greater than the corresponding default threshold, selecting a measurement item maintaining the greatest similarity among the plurality of similarities for a reference time; and providing an ultrasonic image for the selected measurement item as an ultrasonic image.

Abstract: Systems and methods for arthritis therapy are provided. A system may include a digital apparatus, which may include a digital instruction generation unit configured to generate digital therapeutic modules for preventing or ameliorating arthritis, generate specified digital instructions based on the digital therapeutic modules and provide the digital instructions to a first user, and an outcome collection unit configured to collect the first user's execution outcomes of the digital instructions.

Abstract: The present invention relates to a heteroaryl derivative compound and a use thereof. Since the heteroaryl derivative of the present invention exhibits excellent inhibitory activity against EGFR, the heteroaryl derivative can be usefully used as a therapeutic agent for EGFR-associated diseases.

Abstract: A method of manufacturing a laser irradiation device for oral treatment includes (a) molding a base frame having a tongue fixing frame part convexly formed upward so that the tongue is inserted into a lower space thereof and a teeth seating part concavely formed so that human teeth are seated therein, (b) assembling an LED strip with respect to the base frame, the LED strip having a plurality of laser diodes installed on a flexible circuit board to correspond to the shape of the base frame, (c) injecting a liquid light-transparent resin material into an upper light-transparent cover and a lower light-transparent cover respectively corresponding to the shapes of upper and lower parts of the base frame, and (d) respectively pressing the upper light-transparent cover and the lower light-transparent cover vertically upward and downward with respect to the base frame.

Abstract: An aqueous dispersion composition according embodiments of the present invention includes an ethylene-carboxylic acid copolymer, an anti-blocking agent including a polymer wax included in a content of 5 wt % or more based on a weight of the ethylene-carboxylic acid copolymer, and an aqueous dispersion medium. A peak area corresponding to a melting point of 80° C. or less in a differential scanning calorimetry (DSC) graph is 50% or more. Blocking phenomenon is suppressed using the anti-blocking agent while achieving desired heat seal properties.

Abstract: A variable displacement swash plate type compressor control method and a variable displacement swash plate type compressor controlled thereby may include a first determination step of determining whether liquid refrigerant exists within the variable displacement swash plate type compressor; a first operation step of applying power to the field coil assembly and of not applying current to the electronic control valve, when it is determined in the first determination step S1 that the liquid refrigerant exists; a second determination step of comparing an elapsed period of time of operating in the first operation step with a predetermined reference time; and a second operation step of maintaining the power applied in the first operation step to the field coil assembly and applying current to the electronic control valve when the elapsed period of time is greater than or equal to the reference time.

Abstract: Provided is an apparatus for non-invasively monitoring a health condition. The apparatus for monitoring health according to an example embodiment of the disclosure includes: a pulse wave sensor configured to obtain a first pulse wave signal in a first contact state of an object and a second pulse wave signal in a second contact state of the object; and a processor configured to estimate a degree of vasodilation based on an alternating current (AC) component of each of the first pulse wave signal and the second pulse wave signal, configured to monitor a vascular health condition based on the estimated degree of vasodilation, and configured to output a result of monitoring the vascular health condition.

Abstract: A display device includes a light emitting diode electrically connected between a driving voltage line and a common voltage line; a driving transistor electrically connected between the driving voltage line and the light emitting diode; a second transistor electrically connected between a first electrode of the driving transistor electrically connected to the driving voltage line and a data line; a first scan line electrically connected to a gate electrode of the second transistor; a third transistor electrically connected between a second electrode of the driving transistor electrically connected to the light emitting diode and a gate electrode of the driving transistor; and a connection electrode that connects the gate electrode of the driving transistor and the third transistor, wherein at least a part of a contact portion where the connection electrode contacts the third transistor does not overlap the first scan line.

Abstract: Provided is a semiconductor memory device comprising an active region extending in a cell isolation layer, wherein the active region includes a first region and a second region; a bit line intersects the active region; a bit line contact between a substrate and the bit line, wherein the bit line contact is electrically connected to the first region; a bit line spacer that is on side surfaces of the bit line and the bit line contact; a node pad on a lateral side of the bit line spacer, wherein the node pad is electrically connected to the second region; a storage contact that is on the node pad and on a side surface of the bit line spacer, wherein the storage contact includes a first part having a first width and a second part having a second width different from the first width.

Abstract: A semiconductor system includes a controller configured to count the number of error check scrub (ECS) operations and configured to generate ECS information that includes information with regard to an address at which the ECS operation is to be performed based on the number of ECS operations. The semiconductor system further includes a memory apparatus configured to perform the ECS operation on a region that is selected by the ECS information.

Abstract: Methods and apparatuses are described herein for treating a patient with mild cognitive impairment (MCI) or dementia by one or more digital therapeutics. For example, a patient. who has been diagnosed with the MCI or dementia may administer one or more digital therapeutics to the patient to improve a plurality of neurohumoral factors that cause the MCI or the dementia of the patient. The digital therapeutics may include one or more digital instructions that are generated to treat at least one imbalance of the plurality of neurohumoral factors based on at least one neurohumoral change among the plurality of neurohumoral factors by the patient's performance of the one or more digital instructions. The one or more digital instructions may include at least one of an execution environment setting, a lifestyle change, learning, exercising, or affirmation/achievement task.

Abstract: A transistor device includes a substrate, a fin structure extending on the substrate in a direction parallel to a top surface of the substrate, a source region and a drain region provided at an upper portion of the fin structure, a constant current generating layer provided at a lower portion of the fin structure, a gate insulating film provided on both side surfaces and a top surface of the upper portion of the fin structure, and a gate electrode provided on the gate insulating film, wherein the gate electrode is provided on the fin structure and between the source region and the drain region, the constant current generating layer generates a constant current between the drain region and the substrate, and the constant current is independent from a gate voltage applied to the gate electrode.

Abstract: A display device includes: a base substrate having a display region including a first region and a second region, and a non-display region; a first semiconductor layer including polysilicon at the second region; a first conductive layer on a first insulating layer, and including a bottom gate electrode at the first region and a second-first gate electrode at the second region; a second semiconductor layer including an oxide on a second insulating layer at the first region; a second conductive layer on a third insulating layer, and including a top gate electrode at the first region and a second-second gate electrode at the second region; and a third conductive layer on a fourth insulating layer, and including a first source electrode and a first drain electrode connected to the second semiconductor layer, and a second source electrode and a second drain electrode connected to the first semiconductor layer.

Abstract: A method for reinjecting an electrolyte, and a secondary battery capable of being reinjected with an electrolyte are described. The method for reinjecting an electrolyte is a method for reinjecting an electrolyte into a secondary battery in which an electrode assembly and an electrolyte are accommodated in a pouch. The pouch includes an aluminum sheet, in which a functional hole is formed, and a polymer layer stacked on the aluminum sheet. The method includes a reinjection process of injecting an additional electrolyte into the pouch through the functional hole by opening the functional hole, and a sealing process of sealing the functional hole after the reinjection process.

Abstract: The present invention relates to a polycyclic aromatic derivative compound and a high efficiency and long lifetime organoelectroluminescent device which has significantly improved luminous efficiency by using same. The present invention can implement an organoelectroluminescent device with high efficiency and long lifetime, and thus can be effectively used for industrial applications including flat display devices, flexible display devices, monochromatic or white flat lighting devices, and monochromatic or white flexible lighting devices.

Abstract: The present invention relates to a polycyclic compound which can be employed in various organic layers included in an organic light emitting device and contains R substituted with at least one deuterium (D), and to an organic light emitting device which has a long lifespan by comprising same to significantly improve lifespan characteristics thereof. According to the present invention, an organic light emitting device having a long lifespan can be implemented, and thus can be industrially advantageously used in various lighting and display devices, such as a flat panel display device, a flexible display device, a monochromatic or white flat panel lighting device, a monochromatic or white flexible lighting device, a vehicle display device, and a virtual or augmented reality display device.